US Stock MarketDetailed Quotes
ALT Altimmune
- 6.650
- +0.265+4.15%
Close Jun 28 16:00 ET
- 6.670
- +0.020+0.30%
Post 19:59 ET
471.50MMarket Cap-4156P/E (TTM)
6.670High6.300Low6.68MVolume6.390Open6.385Pre Close44.12MTurnover9.50%Turnover RatioLossP/E (Static)70.90MShares14.84052wk High2.73P/B467.77MFloat Cap2.09052wk Low--Dividend TTM70.34MShs Float978.000Historical High--Div YieldTTM5.80%Amplitude-1731.000Historical Low6.603Avg Price1Lot Size
Altimmune Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 15.72%-16.36M | -21.13%-75.81M | 4.47%-16.53M | -36.13%-20.49M | -16.04%-19.38M | -43.48%-19.41M | 20.01%-62.59M | 21.22%-17.31M | 15.33%-15.05M | 11.75%-16.7M |
| Net income from continuing operations | -21.52%-24.39M | -4.41%-88.45M | -46.08%-31.64M | 12.10%-20.67M | 20.12%-16.06M | -3.31%-20.07M | 12.75%-84.71M | 9.33%-21.66M | 29.82%-23.52M | 19.01%-20.11M |
| Operating gains losses | 144.44%8K | -552.94%-154K | -109.22%-20K | 95.92%-2K | -375.00%-114K | 83.64%-18K | -91.15%34K | 149.43%217K | -117.07%-49K | -4.35%-24K |
| Depreciation and amortization | -14.40%107K | -3.25%477K | 309.09%1.89M | -291.49%-552K | -1,960.38%-986K | 5.04%125K | -10.53%493K | 294.87%462K | -149.47%-141K | -29.33%53K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | -87.71%86K | --0 | --0 | 286.60%1.87M |
| Change In working capital | 421.60%5.26M | -158.64%-8.27M | -66.91%821K | -130.21%-1.97M | -916.48%-5.49M | -128.96%-1.63M | 5,721.91%14.11M | 194.69%2.48M | -45.54%6.53M | 80.05%-540K |
| -Change in receivables | 373.98%2.27M | -170.10%-2.31M | -117.88%-324K | -146.70%-814K | -1,395.65%-344K | -254.70%-830K | -49.53%3.3M | -65.23%1.81M | 222.18%1.74M | -102.08%-23K |
| -Change in prepaid assets | 154.63%4.05M | -150.75%-1.35M | 225.99%698K | -829.02%-1.79M | -623.93%-1.84M | -47.83%1.59M | 144.85%2.65M | 14.11%-554K | -110.20%-193K | 111.88%351K |
| -Change in payables and accrued expense | 55.50%-1.07M | -156.56%-4.62M | -63.45%447K | -87.24%635K | -280.88%-3.31M | -184.56%-2.39M | 1,030.79%8.16M | 117.02%1.22M | -47.89%4.98M | -1.05%-868K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 15.72%-16.36M | -21.13%-75.81M | 4.47%-16.53M | -36.13%-20.49M | -16.04%-19.38M | -43.48%-19.41M | 20.01%-62.59M | 21.22%-17.31M | 15.33%-15.05M | 11.75%-16.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -397.11%-39.52M | 118.71%13.73M | -911.31%-7.96M | 117.33%4.4M | 108.14%3.99M | 147,900.00%13.3M | -183.86%-73.4M | -96.06%981K | -237.98%-25.4M | -295.26%-48.97M |
| Net PPE purchase and sale | --0 | 62.70%-47K | --0 | --0 | 121.05%4K | -466.67%-51K | 98.96%-126K | 74.15%-38K | 14.29%-60K | 99.75%-19K |
| Net investment purchase and sale | -395.97%-39.52M | 118.81%13.78M | -881.06%-7.96M | 117.37%4.4M | 108.14%3.98M | --13.35M | -173.39%-73.27M | -95.93%1.02M | -236.80%-25.34M | -249.00%-48.95M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -397.11%-39.52M | 118.71%13.73M | -911.31%-7.96M | 117.33%4.4M | 108.14%3.99M | 147,900.00%13.3M | -183.86%-73.4M | -96.06%981K | -237.98%-25.4M | -295.26%-48.97M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 13.58%-261K | 51.64%86.11M | 169,295.35%72.75M | -98.17%588K | -39.47%13.07M | -109.49%-302K | -12.78%56.78M | -100.34%-43K | 25,548.00%32.06M | 19.78%21.58M |
| Net common stock issuance | 25.19%169K | 54.07%86.82M | --72.74M | -98.15%590K | -45.14%13.35M | 19.47%135K | -13.37%56.35M | --0 | 26,704.20%31.9M | 33.88%24.34M |
| Proceeds from stock option exercised by employees | 178.69%170K | -88.11%113K | -36.59%52K | --0 | --0 | -98.09%61K | 439.77%950K | 7.89%82K | 4,366.67%268K | -2,852.13%-2.59M |
| Net other financing activities | -20.48%-600K | -59.69%-824K | 70.40%-37K | 98.10%-2K | -71.86%-287K | -318.49%-498K | -337.29%-516K | ---125K | ---105K | 33.99%-167K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 13.58%-261K | 51.64%86.11M | 169,295.35%72.75M | -98.17%588K | -39.47%13.07M | -109.49%-302K | -12.78%56.78M | -100.34%-43K | 25,548.00%32.06M | 19.78%21.58M |
| Net cash flow | ||||||||||
| Beginning cash position | 21.62%135.16M | -41.61%111.13M | -31.85%86.9M | -24.65%102.39M | -41.81%104.72M | -41.61%111.13M | 64.15%190.34M | -27.10%127.5M | -21.96%135.89M | 20.01%179.98M |
| Current changes in cash | -776.21%-56.14M | 130.34%24.03M | 394.86%48.26M | -84.64%-15.5M | 94.71%-2.33M | 38.12%-6.41M | -206.48%-79.2M | -206.03%-16.37M | -1,202.89%-8.39M | -282.41%-44.09M |
| End cash Position | -24.55%79.02M | 21.62%135.16M | 21.62%135.16M | -31.85%86.9M | -24.65%102.39M | -41.81%104.72M | -41.61%111.13M | -41.61%111.13M | -27.10%127.5M | -21.96%135.89M |
| Free cash flow | 15.94%-16.36M | -20.96%-75.86M | 4.68%-16.53M | -35.59%-20.49M | -15.88%-19.38M | -43.76%-19.46M | 30.74%-62.71M | 21.59%-17.34M | 15.54%-15.11M | 37.37%-16.72M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
